HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2-Reference-Cited by-同舟云学术

HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2

Published:2016-05-11 Issue:25 Volume:7 Page:37487-37497
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

De Re Valli¹,De Zorzi Mariangela¹,Caggiari Laura¹,Lauletta Gianfranco²,Tornesello Maria Lina³,Fognani Elisa⁴,Miorin Marta⁵,Racanelli Vito⁶,Quartuccio Luca⁷,Gragnani Laura⁴,Russi Sabino²,Pavone Fabio²,Ghersetti Michela⁸,Costa Elena Garlatti⁸,Casarin Pietro⁸,Bomben Riccardo⁹,Mazzaro Cesare⁹,Basaglia Giancarlo¹⁰,Berretta Massimiliano¹¹,Vaccher Emanuela¹¹,Izzo Francesco¹²,Buonaguro Franco Maria³,De Vita Salvatore⁷,Zignego Anna Linda⁴,De Paoli Paolo¹³,Dolcetti Riccardo¹⁴¹⁵

Affiliation:

1. Bio-Proteomics Facility/ Cancer Bioimmunotherapy, Department of Translational Research, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy

2. Liver Unit, Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy

3. Molecular Biology and Viral Oncology Unit, Istituto Nazionale Tumori “Fondazione G. Pascale” - IRCCS, Napoli, Italy

4. Interdepartmental Center for Systemic Manifestations of Hepatitis Virus MASVE, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

5. Cytogenetics and Molecular Biology Unit, Santa Maria degli Angeli Hospital Pordenone, Pordenone, Italy

6. Immunology Section, Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy

7. Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital “Santa Maria della Misericordia”, Udine, Italy

8. Internal Medicine-Liver Unit, Santa Maria degli Angeli Hospital Pordenone, Pordenone, Italy

9. Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy

10. Microbiology-Immunology and Virology Unit, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy

11. Medical Oncology, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy

12. Hepatobiliary Unit, Istituto Nazionale Tumori “Fondazione G. Pascale” - IRCCS, Napoli, Italy

13. Scientific Directorate, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy

14. Cancer Bio-Immunotherapy, Department of Translational Research, Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy

15. University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals;Journal of Personalized Medicine;2023-07-26

2. hsa-miR-17-5p: A Possible Predictor of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir ± Ribavirin Therapy Efficacy in Hepatitis C Infection;Current Microbiology;2022-05-07

3. Possible relationship between IL28B rs12979860 and TLR2 -196 to -174 del/ins polymorphisms and the liver fibrosis stage in hepatitis C patients;Archives of Virology;2021-11-24

4. PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases;Liver International;2020-12-29

5. Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients;Genes & Diseases;2020-09